These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36562395)

  • 21. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15.
    Thompson DA; Khan NW; Othman MI; Chang B; Jia L; Grahek G; Wu Z; Hiriyanna S; Nellissery J; Li T; Khanna H; Colosi P; Swaroop A; Heckenlively JR
    PLoS One; 2012; 7(5):e35865. PubMed ID: 22563472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of RPGR in X-linked retinitis pigmentosa (RP3).
    Vervoort R; Wright AF
    Hum Mutat; 2002 May; 19(5):486-500. PubMed ID: 11968081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mutations of RPGR in Chinese families with X-linked retinitis pigmentosa.
    Zhang Z; Dai H; Wang L; Tao T; Xu J; Sun X; Yang L; Li G
    BMC Ophthalmol; 2019 Nov; 19(1):240. PubMed ID: 31775781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.
    Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
    Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations.
    Sun X; Park JH; Gumerson J; Wu Z; Swaroop A; Qian H; Roll-Mecak A; Li T
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2925-34. PubMed ID: 27162334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical studies of X-linked retinitis pigmentosa in three Swedish families with newly identified mutations in the RP2 and RPGR-ORF15 genes.
    Andréasson S; Breuer DK; Eksandh L; Ponjavic V; Frennesson C; Hiriyanna S; Filippova E; Yashar BM; Swaroop A
    Ophthalmic Genet; 2003 Dec; 24(4):215-23. PubMed ID: 14566651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel de novo frameshift mutation of RPGR ORF15 is associated with X-linked retinitis pigmentosa in a Chinese family.
    Chang W; Ding Q; Tang Z; Liu P; Jiang F; Ke T; Ren X; Wang Z; Liu J; Wang QK; Liu M
    Mol Vis; 2007 Aug; 13():1548-54. PubMed ID: 17893654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of
    Vinikoor-Imler LC; Simpson C; Narayanan D; Abbasi S; Lally C
    Ophthalmic Genet; 2022 Oct; 43(5):581-588. PubMed ID: 36004681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15.
    Bader I; Brandau O; Achatz H; Apfelstedt-Sylla E; Hergersberg M; Lorenz B; Wissinger B; Wittwer B; Rudolph G; Meindl A; Meitinger T
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1458-63. PubMed ID: 12657579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation in retinitis pigmentosa GTPase regulator gene with a distinctive retinitis pigmentosa phenotype in a Chinese family.
    Sheng X; Li Z; Zhang X; Wang J; Ren H; Sun Y; Meng R; Rong W; Zhuang W
    Mol Vis; 2010 Aug; 16():1620-8. PubMed ID: 20806050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
    von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
    JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exon Skipping Through Chimeric Antisense
    Covello G; Ibrahim GH; Bacchi N; Casarosa S; Denti MA
    Nucleic Acid Ther; 2022 Aug; 32(4):333-349. PubMed ID: 35166581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa.
    Sharon D; Sandberg MA; Rabe VW; Stillberger M; Dryja TP; Berson EL
    Am J Hum Genet; 2003 Nov; 73(5):1131-46. PubMed ID: 14564670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene.
    Walia S; Fishman GA; Swaroop A; Branham KE; Lindeman M; Othman M; Weleber RG
    Arch Ophthalmol; 2008 Mar; 126(3):379-84. PubMed ID: 18332319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?
    Veltel S; Wittinghofer A
    Expert Opin Ther Targets; 2009 Oct; 13(10):1239-51. PubMed ID: 19702441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel RPGR-ORF15 mutations in X-linked retinitis pigmentosa patients.
    Gan DK; He CL; Shu HR; Hoffman MR; Jin ZB
    Neurosci Lett; 2011 Aug; 500(1):16-9. PubMed ID: 21683121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation.
    Parmeggiani F; Barbaro V; Migliorati A; Raffa P; Nespeca P; De Nadai K; Del Vecchio C; Palù G; Parolin C; Di Iorio E
    Eur J Ophthalmol; 2017 Mar; 27(2):240-248. PubMed ID: 27768226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing.
    Gumerson JD; Alsufyani A; Yu W; Lei J; Sun X; Dong L; Wu Z; Li T
    Gene Ther; 2022 Feb; 29(1-2):81-93. PubMed ID: 34257417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.